Cargando…
Analysis of polypeptide expression in benign and malignant human breast lesions: down-regulation of cytokeratins.
Malignant progression of tumour cells is caused by the accumulation of genetic defects, which when combined will generate a large phenotypic diversity. Simultaneous quantitation of a large number of gene products in tumour cells is desirable, but difficult to achieve. We have here quantitated the le...
Autores principales: | Franzén, B., Linder, S., Alaiya, A. A., Eriksson, E., Uruy, K., Hirano, T., Okuzawa, K., Auer, G. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074852/ https://www.ncbi.nlm.nih.gov/pubmed/8932346 |
Ejemplares similares
-
Expression of tropomyosin isoforms in benign and malignant human breast lesions.
por: Franzén, B., et al.
Publicado: (1996) -
Detection of polypeptides associated with the histopathological differentiation of primary lung carcinoma.
por: Hirano, T., et al.
Publicado: (1995) -
Polypeptide Expression in Prostate Hyperplasia and Prostate Adenocarcinoma
por: Alaiya, Ayodele, et al.
Publicado: (2000) -
A fine‐needle aspiration‐based protein signature discriminates benign from malignant breast lesions
por: Franzén, Bo, et al.
Publicado: (2018) -
Relationship between TA01 and TA02 polypeptides associated with lung adenocarcinoma and histocytological features.
por: Hirano, T., et al.
Publicado: (1997)